Vaccine News Daily: New tool for studying relapsing malaria infections
“A new tool could be instrumental in transforming the medical community’s search for novel treatments against relapsing malaria infections. Researchers at Seattle BioMed recently used a human-chimeric mouse model to further study Plasmodium vivax malaria parasite liver infections. The scientists used this tool to grow livers from humans. They then infect[ed] the livers with P. vivax to investigate the parasite’s activity, development, and dormancy…” (4/1).